A Phase I, Open-Label, Three-Period, Fixed-Sequence Study To Estimate The Steady-State Effect Of Ketoconazole And Omeprazole On The Single-Dose Pharmacokinetics Of Dimebon [PF-01913539] In Healthy CYP2D6 EM And PM Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Latrepirdine (Primary) ; Ketoconazole; Omeprazole
- Indications Dementia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 18 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.